Outcome

This review of research supports the use of Hyperbaric Oxygen Therapy (HBOT) for treating Alzheimer’s disease (AD). Analyzing 391 articles from 1980-2021 the review found that HBOT shows promise in improving cognitive function in both human and animal models. It suggests that HBOT can be an effective treatment potentially increasing brain health and reducing symptoms of this degenerative condition. Further research is recommended to develop a protocol for maintaining long-term cognitive health in AD patients.

Introduction

Alzheimer’s disease (AD) is the leading cause of dementia in elderly individuals and finding effective treatments is crucial. This review investigates the use of Hyperbaric Oxygen Therapy (HBOT) as a promising treatment for AD. By examining 391 full-text articles from ScienceDirect and PubMed spanning four decades (1980-2021) the paper evaluates the molecular and physiological mechanisms that make HBOT effective in treating brain disorders. The findings suggest that HBOT has numerous benefits in both human and animal models helping to alleviate the symptoms of AD. This literature review strongly supports further research into HBOT as a viable treatment option for maintaining long-term cognitive health in patients with Alzheimer’s disease.

Results

The review article conducted an extensive analysis of 391 full-text articles from ScienceDirect and PubMed databases covering publications from 1980 to 2021. The objective was to evaluate the effectiveness of Hyperbaric Oxygen Therapy (HBOT) in treating Alzheimer’s disease (AD). AD is known as the most common cause of dementia in elderly individuals. The reviewed studies highlight various physiological benefits of HBOT including improved brain function in aging or degenerative brain disorders.

The outcomes of the reviewed clinical and experimental studies suggest that HBOT is effective in treating AD. The therapy appears to benefit the brain by enhancing oxygen supply which is particularly useful in conditions characterized by hypoxia—low oxygen levels. HBOT reportedly helps in reducing reactive oxygen stress which is associated with degeneration in brain disorders like AD.

Although the exact mechanism of how HBOT works in AD treatment remains unclear the accumulated evidence advocates for its use. Both human and animal models demonstrated positive responses to HBOT indicating its potential as an alternative treatment intervention for AD. The review underscores the need for further research to develop a comprehensive and long-term treatment protocol that could sustain cognitive health in AD patients.

In summary this review supports the application of HBOT in managing Alzheimer’s disease calling for additional studies to refine the treatment approach for long-term benefits.

Conclusion

In conclusion this comprehensive review strongly supports the use of hyperbaric oxygen therapy (HBOT) as an effective treatment for Alzheimer’s disease (AD) the most common cause of dementia in the elderly population. By examining 391 full-text articles published between 1980 and 2021 the review highlights the numerous physiological benefits of HBOT for the brain particularly in aging or degenerative conditions like AD. The findings indicate that HBOT can provide significant improvements by potentially addressing the underlying symptoms such as hypoxia and neurodegenerative stress. Although the exact mechanisms of AD remain unknown the positive outcomes in clinical and experimental studies make a compelling case for HBOT’s efficacy. The review advocates for its use not only based on the molecular and physiological mechanisms observed but also on the proven benefits in both human and animal models. Furthermore the review emphasizes the need for continued research to establish a long-term treatment protocol that could ensure sustained cognitive health for AD patients. This reinforces the promising future of HBOT in offering a viable alternative for managing this debilitating disease.